Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Clinical trial NCT06395870 · RECRUITING
Trial details
- NCT number
- NCT06395870
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-09
- Primary completion
- 2026-06-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.